Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04771741 · ClinicalTrials.gov registry record

Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study

A clinical trial, sponsored by Prisma Health-Midlands.

Completed
Registry status
72
Enrollment target

NCT04771741: Completed study, sponsored by Prisma Health-Midlands.

NCT04771741 is a clinical trial that has completed, run by Prisma Health-Midlands. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04771741 has completed, sponsored by Prisma Health-Midlands.

COMPLETED
Registry status
72 participants
Enrollment target

Study Summary

Orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period, despite the ongoing opioid crisis in the United States. While opioid-free multimodal pathways have shown promising results, there remains a lack of published literature evaluating opiate-free multimodal pain protocols for elective outpatient foot and ankle surgeries. This study aims to evaluate post-operative pain following the use of an opioid-free pain treatment plan for patients undergoing foot and ankle surgeries.

Primary Outcome

Study participants will complete a survey at the 2 week follow-up visit asking yes or no if they were satisfied with the opioid-free pain management protocol.

Interventions

  • DRUG Acetominophen
  • DRUG Cyclobenzaprine
  • DRUG Meloxicam
  • DRUG Toradol
  • DRUG Lyrica

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2020-12-01
Est. Completion 2023-04-26
Prisma Health-Midlands

7 total trials

What the finished NCT04771741 record still lists

NCT04771741 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which Acetominophen is the first listed.

NCT04771741 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04771741 about?

NCT04771741 is a clinical study titled "Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study". Orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period, despite the ongoing opioid crisis in the United States. While opioid-free multimodal pathways have shown promising results, there remains a lack of published literature evaluating o...

What is the current status of trial NCT04771741?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2020-12-01. Estimated completion is 2023-04-26.

What interventions are being tested in trial NCT04771741?

The interventions under investigation include: Acetominophen (DRUG), Cyclobenzaprine (DRUG), Meloxicam (DRUG), Toradol (DRUG), Lyrica (DRUG).

Who is sponsoring clinical trial NCT04771741?

This trial is sponsored by Prisma Health-Midlands, which has 7 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04771741, the US trial registry maintained by the National Library of Medicine. NCT04771741 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.